«Irregular» complications of viral pneumonia and, especially, coronavirus pneumonia are most often the deterioration of the course of chronic diseases of the heart, brain, kidneys, and endocrine system. The high prevalence of infection in 2020 makes it necessary to hospitalize and choose the optimal treatment strategy for patients with viral pneumonia and non-organ complications of this disease.

OBJECTIVE

Given the significant role of viral infection in the development of acute and exacerbation of chronic CVD, the purpose of this study was to assess the nature of acute cardiovascular lesions in patients admitted to a rapid hospital with a diagnosis of viral pneumonia and to analyze the preclinical history of their chronic cardiac diseases.

MATERIAL AND METHODS

The analysis was carried out based on the survey and treatment of 191 patients (men 72, women 119), age from 38 to 97 years (average age 59.2 years) admitted to the hospital 15 GKB in the period from 29.04.20 to 01.06.20: U07.1 Coronavirus infection caused by the COVID-19 virus, the virus was identified (confirmed by laboratory testing regardless of the severity of clinical signs or symptoms). Methods for assessing the state of the heart: echocardiography (67 studies), ECG, laboratory indicators — assessment of hemostasis indicators (D-dimer, fibrinogen, APTT, INR).

RESULTS AND CONCLUSION

Signs of acute cardiovascular disease, including coronary disease, are detected in 28—39% of patients, with approximately a similar frequency in groups of patients with viral pneumonia, both with positive and negative results of studies on COVID-19. Forms of severe arterial hypertension of grade 3 are noted in anamnesis in more than 40% of patients with COVID-19 and pneumonia with a serologically confirmed diagnosis of this infection, and echocardiographic signs of atrial enlargement are detected in them in more than 60% of cases. The concentration of one of the markers of thrombus formation, D-dimer, is significantly increased in the bloodstream of patients with COVID-19 pneumonia, its increase may be associated with the area of the prevalence of pulmonary lesions and the incidence of acute cardiovascular diseases.